Vasculature Organotropism in Drug Delivery

Overview

Journal Adv Drug Deliv Rev

Specialty Pharmacology

Date 2023 Aug 17

PMID 37591370

Authors

A Amruta

Dalila Iannotta

Seth W Cheetham

Twan Lammers

Joy Wolfram

Affiliations

Soon will be listed here.

Abstract

Over the past decades, there has been an exponential increase in the development of preclinical and clinical nanodelivery systems, and recently, an accelerating demand to deliver RNA and protein-based therapeutics. Organ-specific vasculature provides a promising intermediary for site-specific delivery of nanoparticles and extracellular vesicles to interstitial cells. Endothelial cells express organ-specific surface marker repertoires that can be used for targeted delivery. This article highlights organ-specific vasculature properties, nanodelivery strategies that exploit vasculature organotropism, and overlooked challenges and opportunities in targeting and simultaneously overcoming the endothelial barrier. Impediments in the clinical translation of vasculature organotropism in drug delivery are also discussed.

Citing Articles

Developing mRNA Nanomedicines with Advanced Targeting Functions.

Wang J, Cai L, Li N, Luo Z, Ren H, Zhang B Nanomicro Lett. 2025; 17(1):155.

PMID: 39979495 PMC: 11842722. DOI: 10.1007/s40820-025-01665-9.

Nanocarrier-mediated cancer therapy with cisplatin: .

Ranasinghe R, Mathai M, Alshawsh M, Zulli A Heliyon. 2025; 10(7):e28171.

PMID: 39839154 PMC: 11747978. DOI: 10.1016/j.heliyon.2024.e28171.

Increasing the biomolecular relevance of cell culture practice.

Ghebosu R, Hui L, Wolfram J J Biomed Sci. 2025; 32(1):3.

PMID: 39748368 PMC: 11697962. DOI: 10.1186/s12929-024-01095-6.

Hyaluronic acid-coated polypeptide nanogel enhances specific distribution and therapy of tacrolimus in rheumatoid arthritis.

Li Y, Wang X, Gao Y, Zhang Z, Liu T, Zhang Z J Nanobiotechnology. 2024; 22(1):547.

PMID: 39238027 PMC: 11378632. DOI: 10.1186/s12951-024-02784-y.

Extracellular Vesicle and Lipoprotein Interactions.

Ghebosu R, Pendiuk Goncalves J, Wolfram J Nano Lett. 2023; 24(1):1-8.

PMID: 38122812 PMC: 10872241. DOI: 10.1021/acs.nanolett.3c03579.

References

Caracciolo G, Pozzi D, Capriotti A, Cavaliere C, Piovesana S, La Barbera G . The liposome-protein corona in mice and humans and its implications for in vivo delivery. J Mater Chem B. 2020; 2(42):7419-7428. DOI: 10.1039/c4tb01316f. View

Jain R, Stylianopoulos T . Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010; 7(11):653-64. PMC: 3065247. DOI: 10.1038/nrclinonc.2010.139. View

Spragg D, Alford D, Greferath R, LARSEN C, Lee K, Gurtner G . Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci U S A. 1997; 94(16):8795-800. PMC: 23135. DOI: 10.1073/pnas.94.16.8795. View

Chakrabarti S, Williams T, Dillman R, Siahaan T . Solution stability of linear vs. cyclic RGD peptides. J Pept Res. 1999; 53(5):530-41. DOI: 10.1034/j.1399-3011.1999.00052.x. View

Smith D, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S . Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med. 1998; 188(1):17-27. PMC: 2525535. DOI: 10.1084/jem.188.1.17. View

St Croix B, Rago C, Velculescu V, Traverso G, Romans K, Montgomery E . Genes expressed in human tumor endothelium. Science. 2000; 289(5482):1197-202. DOI: 10.1126/science.289.5482.1197. View

Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi H, Garin-Chesa P . Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem. 2000; 276(10):7408-14. DOI: 10.1074/jbc.M009604200. View

Harrington K, Mohammadtaghi S, Uster P, Glass D, Peters A, Vile R . Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 2001; 7(2):243-54. View

Pham M, Lee J, Ritter C, Thielemann R, Meyer J, Haselmann U . Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus. PLoS Pathog. 2023; 19(7):e1011052. PMC: 10411793. DOI: 10.1371/journal.ppat.1011052. View

10.

Oh W, Kim S, Choi M, Kim C, Jeong Y, Cho B . Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano. 2010; 4(9):5301-13. DOI: 10.1021/nn100561e. View

11.

Ma L, Li W, Zhang Y, Qi L, Zhao Q, Li N . FLT4/VEGFR3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for bacterial elimination. Autophagy. 2021; 18(6):1385-1400. PMC: 9225223. DOI: 10.1080/15548627.2021.1985338. View

12.

Kong G, Braun R, Dewhirst M . Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 2001; 61(7):3027-32. View

13.

Michaelis K, Hoffmann M, Dreis S, Herbert E, Alyautdin R, Michaelis M . Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther. 2006; 317(3):1246-53. DOI: 10.1124/jpet.105.097139. View

14.

Nishida-Aoki N, Tominaga N, Kosaka N, Ochiya T . Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake. J Extracell Vesicles. 2020; 9(1):1713527. PMC: 7006786. DOI: 10.1080/20013078.2020.1713527. View

15.

Plopper G, McNamee H, Dike L, Bojanowski K, Ingber D . Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell. 1995; 6(10):1349-65. PMC: 301292. DOI: 10.1091/mbc.6.10.1349. View

16.

Aird W . Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007; 100(2):158-73. DOI: 10.1161/01.RES.0000255691.76142.4a. View

17.

Di J, Du Z, Wu K, Jin S, Wang X, Li T . Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size. Pharm Res. 2022; 39(1):105-114. PMC: 8791091. DOI: 10.1007/s11095-022-03166-5. View

18.

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

19.

Frohlich E . The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012; 7:5577-91. PMC: 3493258. DOI: 10.2147/IJN.S36111. View

20.

Morad G, Carman C, Hagedorn E, Perlin J, Zon L, Mustafaoglu N . Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier Transcytosis. ACS Nano. 2019; 13(12):13853-13865. PMC: 7169949. DOI: 10.1021/acsnano.9b04397. View